|
Experimental Models for Testing Novel Targets for Pancreatic Cancer Cell Invasion
|
1R21CA124931-01A1
|
$167,475
|
$167,475
|
MOUSA, SHAKER
|
ALBANY COLLEGE OF PHARMACY
|
|
Fibronectin Polymerization: Effects on Cell Signaling
|
5R01CA069612-12
|
$271,548
|
$135,774
|
MC KEOWN-LONGO, PAULA
|
ALBANY MEDICAL COLLEGE
|
|
ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE
|
2R44CA114126-02
|
$419,983
|
$419,983
|
Lim, Mark
|
AMBERGEN, INC
|
|
RTOG Tissue Bank
|
5U24CA114734-04
|
$793,026
|
$793,026
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
Generation of a Modified DT_IL3 Fusion Toxin
|
1R43CA134162-01
|
$122,830
|
$122,830
|
VANDERSPEK, JOHANNA
|
ANJIN GROUP, INC.
|
|
Hybrid synthetic targeted lenti-VLP nanoparticle for gene delivery
|
1R43CA137966-01
|
$299,600
|
$299,600
|
WOODLE, MARTIN
|
APARNA BIOSCIENCES CORPORATION
|
|
Human Apyrase to Disrupt Cancer Therapy
|
1R43CA130192-01A2
|
$196,745
|
$196,745
|
CHEN, RIDONG
|
APT THERAPEUTICS, INC.
|
|
Molecular Target Focused Discovery of Anticancer Drugs
|
2R01CA090441-06A2
|
$381,250
|
$53,375
|
PETTIT, GEORGE
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Antibody therapeutics - feasibility study on hormone-refrectory prostate cancer m
|
1R43CA137929-01
|
$185,061
|
$92,531
|
CHANG, JIA
|
ATTOGEN, INC
|
|
Targeted Gene Therapy for Lymphoma
|
5R01CA113454-03
|
$256,177
|
$256,177
|
SMITH, BRUCE
|
AUBURN UNIVERSITY AT AUBURN
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$38,496
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
SV40 Pathogenesis of Human Infections
|
5R01CA104818-05
|
$467,229
|
$467,229
|
BUTEL, JANET
|
BAYLOR COLLEGE OF MEDICINE
|
|
NR4A Nuclear Receptor Function in Leukemia
|
5R01CA111411-03
|
$258,529
|
$258,529
|
CONNEELY, ORLA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Enhancing T Cell Therapy of Cancer
|
2P01CA094237-06
|
$1,905,870
|
$400,233
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
SPORE in Lymphoma
|
5P50CA126752-02
|
$2,266,618
|
$2,266,618
|
Heslop, Helen
|
BAYLOR COLLEGE OF MEDICINE
|
|
Proteosome Inhibition Therapy for Hematologic Malignancy
|
5K23CA113775-03
|
$134,015
|
$134,015
|
HORTON, TERZAH
|
BAYLOR COLLEGE OF MEDICINE
|
|
Genetic analysis of mouse chromosome 11
|
5R01CA115503-03
|
$475,228
|
$475,228
|
Justice, Monica
|
BAYLOR COLLEGE OF MEDICINE
|
|
Role of PML nuclear body proteins for establishment of EBV latent infection
|
5R01CA124309-03
|
$258,530
|
$258,530
|
Ling, Paul
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanisms of Cellular Transformation by HTLV-1 TAX
|
5R01CA077371-10
|
$268,279
|
$268,279
|
Marriott, Susan
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-02S1
|
$117,286
|
$16,420
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-02
|
$1,515,000
|
$212,100
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mitotic Regulation of Apoptosis in Leukemia
|
5R01CA109478-03
|
$206,823
|
$206,823
|
PATI, DEBANANDA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Clinical Oncology Research Training Program
|
5K12CA090433-07
|
$707,872
|
$141,574
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Pediatric Oncology Research Training Program
|
5T32CA115303-03
|
$372,589
|
$372,589
|
Poplack, David
|
BAYLOR COLLEGE OF MEDICINE
|
|
Chimeric T Cell for Therpay of Hodgkin Disease
|
1R01CA131027-01A1
|
$308,743
|
$308,743
|
SAVOLDO, BARBARA
|
BAYLOR COLLEGE OF MEDICINE
|
|
Mechanism and Consequences of Telomere Dysfunction
|
1R01CA133249-01
|
$318,513
|
$318,513
|
Songyang, Zhou
|
BAYLOR COLLEGE OF MEDICINE
|
|
Novel Strategies for Immunotherapy of Cancer
|
5R01CA101795-05
|
$263,284
|
$223,791
|
Wang, Rongfu
|
BAYLOR COLLEGE OF MEDICINE
|
|
Improving the Efficacy of Dendritic Cell Vaccines
|
5P01CA084512-07
|
$985,145
|
$985,145
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
Subpopulations of Human Dendritic Cells
|
5R01CA078846-10
|
$292,811
|
$292,811
|
Banchereau, Jacques
|
BAYLOR RESEARCH INSTITUTE
|
|
A Pull-Push Strategy for Lymphoma Immunotherapy
|
5K08CA105064-05
|
$128,547
|
$128,547
|
Song, Wenru
|
BAYLOR RESEARCH INSTITUTE
|
|
Regulation of p21waf1/cip1 by Rho and Ras signaling
|
5R01CA030721-06
|
$182,278
|
$18,228
|
OLSON, MICHAEL
|
BEATSON INSTITUTE FOR CANCER RESEARCH
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-25
|
$453,250
|
$4,533
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Training Patients and Partners for HSCT: A Novel Coping Skills Intervention
|
5R03CA130725-02
|
$84,500
|
$84,500
|
Lawsin, Catalina
|
BERNARD M. BARUCH COLLEGE
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-03
|
$335,708
|
$335,708
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Eastern Cooperative Oncology Group
|
5U10CA080775-10
|
$128,678
|
$9,007
|
ATKINS, MICHAEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Downstream of Akt in the tumor vessel
|
1R01CA131152-01A1
|
$446,580
|
$446,580
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Angiogenesis in Breast Cancer
|
5R01CA106263-04
|
$318,352
|
$143,258
|
BENJAMIN, LAURA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Reconstitution of T cell immunity after UCB transplantation: The role of Treg
|
1R21CA123855-01A2
|
$391,915
|
$391,915
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Expression and Function of Tob in T Lymphocytes
|
7R01CA104596-04
|
$318,352
|
$254,682
|
BOUSSIOTIS, VASSILIKI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-14
|
$139,719
|
$27,944
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Novel Strategies for Treatment of Myeloproliferative Disorders
|
1R01CA131664-01A1
|
$352,750
|
$352,750
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Oncogene-Induced Evasion from Apoptosis
|
5R01CA105306-04
|
$318,352
|
$318,352
|
KHOSRAVI-FAR, ROYA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Gab2 and Shp2 in Hematopoietic Signalling
|
5R01CA114945-11
|
$396,987
|
$396,987
|
NEEL, BENJAMIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Fusion Proteins in the Molecular Pathogenesis of APL
|
5R01CA074031-13
|
$351,467
|
$351,467
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of POZ-zinc finger proteins in hemopoietic malignacies
|
7R01CA102142-05
|
$330,443
|
$165,222
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
X-RAR alpha proteins: Molecualr Pathogenesis of Acute Promyelocytic Leukemia
|
7R37CA071692-12
|
$348,711
|
$348,711
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Control of Protein Translation in Cancer Pathogenesis
|
7U01CA084292-10
|
$697,531
|
$697,531
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Mouse model of infant acute megakaryocytic leukemia
|
5K08CA111399-04
|
$134,379
|
$134,379
|
Raffel, Glen
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Rectifying defects in tumor vasculature to improve chemo- and radiation therapies
|
1R01CA129339-01A1
|
$352,750
|
$352,750
|
SENGER, DONALD
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Suppression of FOXO3a as a determinant in Bcr-Abl-mediated transformation
|
1F32CA132365-01
|
$46,826
|
$46,826
|
Singh, Amrik
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
Total relevant funding to Hematology for this search: $482,375,634
|